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HYSTEROSALPINGOGRAPHY:
TECHNIQUE AND APPLICATIONS (VIEW)
Hysterosalpingography (HSG) remains an important radiologic procedure in the investigation of infertility. HSG demon­
strates the morphology of the uterine cavity, the lumina, and the patency of the fallopian tubes. In this review article, we 
present the technical parameters of the examination, indications, contraindications, and possible complications of HSG. We 
also illustrate a variety of abnormalities of the uterus and fallopian tubes that can be detected accurately with HSG.
Key words: hysterosalpingography, fallopian tube, infertility.
Гістеросальпінгографія (ГСГ) є важливою рентгенологічної процедурою в розслідуванні безпліддя. ГСГ 
демонструє морфологію порожнини матки в просвіті і прохідності маткових труб. У цій статті ми представляємо 
технічні параметри експертизи, показань, протипоказань і можливих ускладнень ГСГ. Ми також ілюструємо різні 
аномалії розвитку матки та маткових труб, що може бути точно виявлено за допомогою ГСГ.
Ключові слова: гістеросальпінгографія, маткові труби, безпліддя.
Гистеросальпингография (ГСГ) является важной рентгенологической процедурой в расследовании бесплодия. 
ГСГ демонстрирует морфологию полости матки в просвете и проходимости маточных труб. В этой статье мы пред­
ставляем технические параметры экспертизы, показаний, противопоказаний и возможных осложнений ГСГ. Мы 
также иллюстрируем различные аномалии развития матки и маточных труб, что может быть точно обнаружено с 
помощью ГСГ.
Ключевые слова: гистеросальпингография, маточные трубы, бесплодие.
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Hysterosalpingography (HSG) is the radiographic 
evaluation of the uterine cavity and fallopian tubes after 
the administration of a radio-opaque medium through 
the cervical canal. The first HSG was performed in 
1910 and was considered to be the first special radio­
logic procedure. A properly performed HSG can de­
tect the contour of the uterine cavity and the width of 
the cervical canal. Further contrast medium injection 
will outline the cornua isthmic and ampullary portions 
of the tubes, and will show the degree of spillage. If 
a properly performed HSG shows no uterine cavity 
abnormality, it is very unlikely that other modalities 
would do so. Although this procedure is considered 
diagnostic, there may also be a possible therapeutic 
benefit from the flushing effect.
Indications and Contraindications
HSG is used predominantly in the evaluation of in­
fertility. Despite the arrival of newer imaging modalities, 
HSG still remains the best procedure to image the fallopi­
an tubes. Although evaluating feminine infertility, with or 
without the presence of repeated miscarriages, is the main 
indication for this method, it can also be used in other cas­
es, such as pain in the pelvis tract, congenital or anatomic 
abnormalities, anomalies of the menstrual cycle, and ab­
normal menses. Also, it is sometimes used as a preoper­
ative control for women who are about to have uterine 
or tubal surgery. Soares and coworkers showed that HSG 
had a sensitivity of 58% and a positive-predictive value 
of 28.6% for polypoid lesions, and a sensitivity of 0% for 
endometrial hyperplasia. The same study showed HSG 
to have a sensitivity of 44.4% for uterine malformations, 
and a sensitivity of 75% for the detection of intrauterine 
adhesions. The main contraindication of the examination 
is possible pregnancy. This contraindication can be avoid­
ed by performing the examination before the ovulation 
phase, between the 7th to 10th day of the menstrual cycle. 
Because of the scattering risk, the examination should be 
avoided when there is active intrapelvic inflammation. 
Another contraindication is vaginal or uterine bleeding 
because of the risk of unrestrained bleeding, which could 
lead to transfusion or surgical recovery procedures. Fi­
nally, the examination should not be performed in cases 
of severe cardiac or renal deficiency, or in cases of recent 
uterine or tubal surgery.
Technique
Patient Preparation
The procedure is performed in the first half of the 
menstrual cycle following cessation of bleeding. The 
endometrium is thin during this proliferative phase, 
which facilitates better image interpretation and should 
also ensure that there is no pregnancy. The patient is 
asked to refrain from unprotected sexual intercourse 
from the date of her period until after the investigation 
to be certain there is no risk of pregnancy. Examination 
in the second half of the cycle is avoided because the 
thickened secretory-phase endometrium increases the 
risk of venous intravasation and may cause a false-pos­
itive diagnosis of cornual occlusion.
Antibiotics might be required 1 day before and for 
a few days after the examination if previous inflamma­
tions are present in the patient’s clinical history.
Antibiotics are required after the examination when 
the maneuvers are fairly sanguineous or if the fallopian 
tubes present a certain degree of dilation. The suggest­
ed antibiotic regimen is metronidazole 1 g rectally at
the time of the procedure, plus doxycycline 100 mg 
twice daily for 7 days.Steroid (prednisolone) premed­
ication is prescribed in asthmatics when intravenous 
contrast is used; there-fore, it is reasonable to do the 
same for HSG because intravasation is also possible 
from this procedure.
Catheterization Technique
For the catheterization technique, the patient is 
placed on the fluoroscopic machine in a gynecologic 
examination position. After cleaning the external gen­
ital area with antiseptic solution, the vagina is dilated 
by a gynecologic dilator. The cervix is localized and 
cleansed with iodine solution. Afterward, the uterine 
cervix is straightened by one (at the 12 o’clock posi­
tion) or two (at the 9 and 3 o’clock positions) surgi­
cal forceps exercising a degree of pulling. Next, the 
outside uterine cervix ostium is catheterized. The 
catheterization can be performed in two ways. In the 
authors’ country, a salpinographer with a bell-shaped 
end (diameter depends on the case) is pushed through 
the vagina and fits in the external uterine cervix osti­
um. In the second technique, the salpingographer has 
a plastic cup-shaped end that is fitted to the external 
uterine cervix ostium, creating a void phenomenon. 
In both techniques, there is a syringe with iodinated 
hydrosoluble contrast medium at the other end of the 
salpingographer. The vagina dilator is taken off after 
catheterization of the external uteri cervix ostium and 
before administration of the contrast medium.
Contrast Media
In the past, oil-soluble contrast media were mainly 
used. Today, we use all available iodinated hydrosol­
uble contrast media. According to international liter­
ature, the use of oil-soluble contrast media increases 
the pregnancy rate and contributes to a decrease in 
conception time after the salpingography is performed. 
However, Spring and coworkers found that there is no 
evidence that the choice of the contrast material affects 
the rate of term pregnancy. Moreover, they reported 
that oil-soluble contrast media may promote granulo­
matous inflammation in the presence of obstructed or 
inflamed fallopian tubes.
Radiological Views
One conventional radiograph of the pelvis (on a 24­
30 cm radiologic film) is necessary before the contrast 
medium is administrated into the uterine cavity so that 
possible intrapyelic masses or calcifications will not 
complicate interpretation of the images. A metallic 
marker is placed over one side of the pelvis to indicate 
the right or left side of the patient. Next, the examina­
tion is performed under fluoroscopic control so that ra­
diographs can be taken during the filling of the uterine 
cavity (usually 2-3 cm of contrast medium is sufficient) 
and again during the filling of the fallopian tubes. Final­
ly, after the removal of the salpingographer, we radio­
graphically check the presence of contrast medium in 
the peritoneal cavity. The total amount of injected con­
trast medium should not exceed 10 mL. Additional spot 
radiographs are obtained to document any abnormality 
that is seen. Before the first radiograph, we also fluoro- 
scopically check the reflux of the contrast medium.
Complications
The two most common complications of HSG are 
pain and infection. These and other complications and 
side effects are summarized below.
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•  Uterine contractions and discomfort due to the 
introduction of contrast medium into the uterine cavi­
ty: The most common type of pain referenced is subab­
dominal colic caused by dilation of the uterine cavity. 
A more diffuse pain, caused by irritation of the peri­
toneum due to the contrast medium, has also been re­
ported. Pain can be minimized by slowly injecting the 
contrast medium and using isosmolar contrast agents.
•  Postprocedural infection: Spreading and gener­
alization of intrapyelic inflammation may happen in 
cases of chronic inflammation and hydrosalpinges, or 
after severe uterine injury caused by the examination 
maneuver.
•  Vasovagal reaction: A possible reaction to ma­
nipulation of the cervix or inflation of a conclusion 
balloon in the cervical canal.
•  Traumatic elevation of endometrium by the in­
serted cannula: A complication which does not cause 
significant consequences.
•  Uterine perforation and tubal rupture: These 
complications are very rare.
•  Venous or lymphatic intravasation of contrast me­
dia: With a water-based contrast medium there is no ad­
verse effect on the patient, but it can make interpretation 
of the image difficult. It occurs more commonly in the 
presence of fibroids or tubal obstruction. Extravasation 
of the contrast medium could occur if the contrast me­
dium is administered too quickly, if the endometrium is 
injured during the catheterization, or if the examination 
is performed during menstruation. Extravasation is also 
possible when common or special inflammations of the 
endometrium are present due to the intercourse rate be­
tween the uterine vein and the ovarian veins.
•  Allergic reaction to contrast media: Such a reac­
tion is very uncommon with the use of the low-osmolar 
nonionic contrast agents currently available.
•  Radiation exposure to the ovaries: Exposure is 
minimal and can be reduced if the proper technique is 
utilized.
Normal Findings
On face radiographs, the uterine cavity has a nor­
mal trigonal shape and the apex of the triangle corre­
sponds to the isthmus, which is nearly 3.7 cm wide. 
The apex is pointed downwards and connected to the 
internal ostium of the cervix uteri, which is 2.5 cm in 
total length. The base of triangular uterine cavity is the 
fundus, which can be concave, flattened, or slightly 
convex. On both sides of its base, in the area of the 
lateral horns, the two fallopian tubes are drowned. The 
fallopian tubes are separated into three segments: isth­
mus (attached to the uterus, not imaged in several cas­
es), ampullary (in the middle, the longest and widest 
segment), and bell-shaped (to the distal end). There are 
two ostiums: the internal or uterine, and the external 
or abdominal. From the abdominal ostium, the con­
trast medium disperses and diffuses into the peritone­
al cavity. Remaining contrast medium in the furrows 
of the peritoneum can be observed up to 3 hours after 
administration. Very often, the contrast medium in the 
rectouterine pouch of the peritoneum (Douglas’ space) 
can demonstrate the profile of the coordinate ovary.
Congenital Uterus Anomalies
Congenital uterus anomalies are caused by incom­
plete junction of the paramesonephric ducts (Muller 
ducts), or Extravasations of the contrast medium.
The true incidence and prevalence of mullerian 
duct anomalies are difficult to assess. Examination of 
different patient populations, nonstandardized clas­
sification systems, and differences in diagnostic data 
acquisition has resulted in widely disparate estimates, 
with a reported prevalence that ranges from 0.16 to 
10%. As a result of selection bias, a prevalence of 8 
to 10% has been reported in women being evaluated 
with HSG because of recurrent pregnancy loss. The 
overall data suggest that the prevalence both in women 
with normal fertility and in women with infertility is 
approximately 1%, and the prevalence in women with 
repeated pregnancy loss is approximately 3%.
While the majority of women with mullerian duct 
anomalies have little problem conceiving, they have 
higher associated rates of spontaneous abortion, pre­
mature delivery, and abnormal fetal position and dys­
tocia at delivery. Most studies report an approximate 
frequency of 25% for associated reproductive prob­
lems, compared with 10% in the general population. 
Primary infertility in these women usually has an ex­
tra uterine cause and is not generally attributable to 
mullerian duct anomalies alone. Additionally, cervical 
incompetence has been reported to be associated with 
these anomalies.
According to the American Society of Reproduc­
tive Medicine, there are seven different classes of mul­
lerian duct anomalies:
Class I: Segmental agenesis or variable degrees of 
uterovaginal hypoplasia. The anomaly can be detected, 
because of the amenorrhea, before HSG is performed.
Class II: Unicornuate uteri that represent partial or 
complete unilateral hypoplasia. In rare cases of degen­
eration of the mesonephric duct, the uterine cavity ap­
pears monocular when imaged, placed right or left of 
the middle line. The unicornuate uterus contacts only 
the coordinate fallopian tube.
Class III: Didelphys uterus. This is a rare abnor­
mality that results from complete nonfusion of the 
mullerian ducts, and includes the duplication of the 
uterine cavity, cervix neck, and vagina. Rarely, this 
uterus has a single vagina.
Class IV: Bicornuate uterus that demonstrates 
incomplete fusion of the superior segments of the 
uterovaginal canal. The uterine cavity is divided in 
two; each half has a narrow-length shape and stands 
apart from the other.
Class V: Septate uteri that represent partial or com­
plete nonresorption of the uterovaginal septum.
Class VI: Arcuate uterus resulting from nearly 
complete resorption of the septum. Along with the pre­
vious anomaly, these are the most common congenital 
anomalies (50%) in cases detecting female infertility.
Class VII: Anomalies that comprise sequelae of in 
utero diethyloestradiol exposure.
Another congenital anomaly, caused by inadequate 
hormonic stimulation as a fetus, is small uterine cavi­
ty size with normal vaginal length. This is a common 
finding in cases of female infertility.
Abnormal Findings
Fibromyomas
While fibromas are diagnosed by suprapubic ultra­
sound, submucosa fibromyomas are imaged as smooth 
filling defects in the uterine cavity. Differential diagno­
sis must be made from endometrial polyps or possible
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pregnancy. Small intramural fibromyomas do not distort 
the endometrial cavity and are not visualized on HSG. 
Subserous fibromyomas can provoke smooth filling de­
fects or smooth repression of the fallopian tubes only if 
they are located in the lateral walls of the uterus.
Endometrial Polyps
Endometrial polyps are focal overgrowths of the 
endometrium. They usually manifest as well-defined 
filling defects and are best seen during the early filling 
stage. Small polyps may be obscured when contrast 
material completely fills the uterine cavity and may 
be indistinguishable from a small submucosal myoma. 
Sonohysterography has become the preferred method 
of imaging endometrial polyps.
Internal Endometriosis (Adenomyosis)
Adenomyosis is caused by the presence of ectopic 
islets of active endometrium in the muscularis wall of 
the uterus. It is usually imaged as a pointed projection 
of 2 to 3 mm length, perpendicular to the uterine wall 
after contrast medium administration. Rarely, this is 
imaged as a sack-shaped projection filled by contrast 
medium, 4 mm to 1 cm in length. Differential diag­
nosis should include the hyperplasia of the endome­
trium and the entrance of the contrast medium in the 
myometrium or in the nutrient arteriole of submucosa 
fibromyomas.
Uterine Cancer
Uterine cancer manifests as an irregular filling de­
fect, but is rarely diagnosed by the HSG method.
Intrauterine Adhesions
Intrauterine adhesions are most commonly caused 
by endometrial trauma of curettage. They are also seen 
in patients with chronic endometriosis due to tubercu­
losis. Genital tuberculosis primary affects the fallopian 
tubes, and 50% of patients with tubal disease also have 
a uterine abnormality. Intrauterine adhesions manifest 
as irregular filling defects, most commonly as linear 
filling defects arising from one of the uterine walls.
Hydrosalpinx
HSG is the best method for visualizing and eval­
uating the fallopian tubes. Hydrosalpinx is a common 
finding that results from a previous inflammation of 
the fallopian tubes (salpingitis). This is usually the se­
quelae of distal tubal occlusion, leading to dilation of 
the proximal segment. The radiologic image shows a 
dilated lumen in one or more spots, and the contrast 
medium will not make its way to the peritoneal cavity
Tuberculated Salpingitis
This entity usually causes distant fallopian tube 
end obliteration. In extensive infections, multiple con­
strictions along the course of fallopian tube can form, 
resulting in areas of dilation and stenosis. Abnormal 
uterine and vaginal profiles are observed in cases of 
widespread infection.
Salpingitis Isthmica Nodosa
Salpingitis isthmica nodosa is a disease of un­
known etiology, characterized by multiple small out- 
pouchings or diverticula affecting one or both fallopian 
tubes. It is presumably caused by pelvic inflammatory 
disease or endometriosis and is associated with ectopic 
pregnancy and infertility.
Nondrawing o f the Fallopian Tubes
This is the most common finding during the exam­
ination and is usually caused by poor technique, spasm, 
or obliteration of the fallopian tube. Poor technique in­
cludes imperfect straightening of the external cervical 
ostium or an inadequate amount of contrast medium in 
the uterine cavity. The cornual portion of the fallopian 
tube is encased by the smooth muscle of the uterus and, 
if there is a spasm of the muscle during HSG, one or 
both tubes may not fill. Using radiography, tubal spasm 
cannot be distinguished from tubal occlusion. This could 
be avoided by progressive administration of the contrast 
medium or, when the spasm occurs, administration of a 
spasmolytic agent to relieve spasm, helping differentiate 
cornual spasm from true occlusion. Obliteration is usu­
ally caused by previous inflammation or uterine surgery 
and manifests as nonopacification or abrupt cutoff of the 
fallopian tube with no free intraperitoneal spillage.
External Adhesions
External adhesions occur secondary to previous 
inflammation or surgery, similar to the causes of tubal 
occlusion. Peritubal adhesions prevent contrast materi­
al from flowing freely around the bowel loops as seen 
in normal cases, and most commonly manifest as loc- 
ulation of the contrast material around the ampullary 
portion of the tube.
Conclusion. HSG remains the front-line imaging 
modality in the investigation of infertility. It is an ac­
curate means of accessing the uterine cavity and tubal 
patency, but has a
low sensitivity for the diagnosis of pelvic adhe­
sions, which is why it cannot replace laparoscopy. It 
requires knowledge of the female anatomy as well as 
skillful technique in order to avoid pitfalls and misin­
terpretations.
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АДГЕЗИВНА АКТИВНІСТЬ ШТАМІВ МІКРООРГАНІЗМІВ, 
ІЗОЛЬОВАНИХ ВІД ХВОРИХ З СЕЧОКАМ’ЯНОЮ ХВОРОБОЮ
Вивчено особливості прояву адгезивних властивостей (АВ) штамів Enterobacteriaceae, ізольованих від хворих 
з сечокам'яною хворобою для розуміння механізму відбору епідемічно значущих патогенів з подальшою розроб­
кою нових терапевтичних підходів до прогнозування та лікування хворих. Найбільші показники адгезії визначені для 
Escherichia coli, Klebsiella pneumonia, Enterobacter cloaceae.
Ключові слова: сечокам'яна хвороба, адгезивна активність, мікроорганізми.
Изучены особенности проявления адгезивных способностей (АС) штаммов Enterobacteriaceae, изолированных 
от больных мочекаменной болезнью для понимания механизма отбора эпидемично значимых патогенов с дальней­
шей разработкой новых терапевтических подходов к прогнозированию и лечению больных. Самые большие показа­
тели адгезии были получены для Escherichia coli, Klebsiella pneumonia, Enterobacter cloaceae.
Ключевые слова: мочекаменная болезнь, адгезивная активность, микроорганизмы.
The features of display adhesive properties (AV) strains of Enterobacteriaceae, isolated from patients with urolithiasis 
for understanding the mechanism of selection of relevant epidemiological pathogens, followed by the development of new 
therapeutic approaches to predicting and treating patients. The highest rates of adhesion determined for Escherichia coli, 
Klebsiella pneumonia, Enterobacter cloaceae.
Key words: urolithiasis, аdhesive activity.
Етіопатогенез розвитку сечокам’яної хвороби 
(СКХ) до цього часу остаточно не встановлений. 
Механізм утворення каменів пов’язаний з порушен­
ням процесів обміну на рівні клубочково-канальце- 
вої системи, з утворенням білково-полісахаридної 
«матриці». Подальше зростання сформованого мі­
кроліту залежить від порушення пасажу сечі, за­
пального процесу в нирках, в умовах посиленої 
седиментації солей, ступеня іонно-електролітного 
дисбалансу [1, 2].
В розвинених країнах світу із 10 млн. населення 
400 тис. страждають на СКХ. В деяких районах хво­
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